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In public databases, we identified sequences reported
as human genes expressed in kidney mesangial cells. The
similarity of these genes to paramyxovirus matrix, fusion,
and phosphoprotein genes suggests that they are derived
from a novel paramyxovirus. These genes are sufficiently
unique to suggest the existence of a novel paramyxovirus
genus.
T
he identification of novel viruses, particularly those
with the potential to cause human disease, has impor-
tant public health and scientific implications. Examples of
emerged or recently identified viruses affecting humans
include HIV (1), hepatitis C virus (2), West Nile virus (3),
severe acute respiratory syndrome (SARS)-associated
coronavirus (4), human coronavirus from the Netherlands
(HCoV-NL) (5), and Ebola virus (6). Among the paramyx-
oviruses, Nipah virus, Hendra virus, and human metapneu-
movirus were recently described as causing disease in
humans (7–9). 
We now report as viral sequences particular nucleotide
sequences previously considered to be human genes these
sequences were named Angrem52 and Angrem104. These
genes’ expression in human kidney mesangial cells was
reportedly upregulated by treatment with angiotensin II
(10,11). However, these genes appear to encode viral pro-
teins with striking homology to those of paramyxoviruses.
A careful analysis of these sequences suggests that they
actually belong to the Paramyxoviridae and represent a
novel genus in this virus family. Given the identification of
these putative “orphan paramyxovirus” (putative OPmV)
sequences from human cells, the putative OPmVmay cause
human infections.
The Study 
A BLAST search restricted to mammalian protein
sequences was performed through the NCBI Web page
(http://www.ncbi.nlm.nih.gov/BLAST) by using the Nipah
virus matrix protein sequence as the query. One sequence,
accession number AAK76747, with homology to the Nipah
virus matrix protein, was identified. This protein, called
Angrem52 (for angiotensin II-induced, renal mesangial cell
gene 52), displays 53% amino acid identity and 73% amino
acid similarity over 337 amino acids (aa) to the Nipah virus
matrix protein (data not shown). The Angrem52 protein
sequence is derived from a theoretical translation of an
open reading frame (ORF) from nucleotides (nt) 16 to 1038
within the 3170-nt long Angrem52 nucleotide sequence
(GenBank accession no. AY040225). This notable homolo-
gy suggests that Angrem52 is actually a paramyxovirus M
gene (Figure 1A).
Upon further analysis of sequences within the
Angrem52 cDNA downstream of the putative matrix gene,
several relatively short ORFs were found to encode pep-
tides with homology to paramyxovirus fusion (F) proteins.
Modification of the reported Angrem52 sequence in sever-
al positions yields what appears to be a full-length or near
full-length paramymyxovirus fusion (F) protein gene,
which would be separated from the M ORF by 355 nt
(Figure 1A). Specifically, the F ORF within the original
Angrem52 sequence begins at position 1393 but appears to
terminate prematurely with a stop codon at 2118. To obtain
what appears to be a “full-length” F ORF, several modifica-
tions were made to the reported sequence in order to to
incorporate the additional “F-like” sequences. An Aat posi-
tion 2110 was deleted. AT at position 2155 was deleted. A
single nucleotide, either C or T, was added between posi-
tions 2296 and 2297. AT was deleted at 2461. The theoret-
ical translation of this modified ORF yields a protein of 546
aa, the same length as the Nipah virus F protein (data not
shown). A pairwise alignment of the resulting protein with
the F protein of Nipah virus shows 32% identity and 53%
similarity over 509 aa (data not shown). Within this protein,
a putative fusion peptide is readily identifiable based on
homology to those of other paramyxoviruses (Figure 1B).
Although the cleavage site adjacent to the fusion peptide is
typically a basic amino acid, the reported Angrem52 cDNA
sequence has an acidic glutamic acid at this position
(Figure 1B). Both Nipah and Hendra viruses possess F pro-
teins that are cleaved at the expected site (Figure 1B) but
are apparently processed by novel but ubiquitous proteases.
Cleavage of these sites can occur even when the residue
immediately left of the cleavage site is mutated to a nonba-
sic residue (A. Maisner, R.E. Dutch, pers. comm.). 
Other features common to paramyxovirus fusion pro-
teins, type I transmembrane glycoproteins, are a signal
sequence, a transmembrane domain, and 2-heptad repeats.
The 2- heptad repeats play an essential role in membrane
fusion and are able to form trimeric coiled coils (13). For
the putative OPmV F, a potential signal sequence from
residues 1 to 23 and a potential transmembrane domain is
found between residues 497 and 516. Further, the putative
OPmV F has heptad repeats in the positions expected for a
paramyxovirus F protein (residues 108–190 and 428–481). 
Paramyxovirus genes are separated by cis-acting ele-
ments in the genome. The signals that lie between genes
include a gene-end signal, an intergenic sequence, and a
gene-start signal. The Angrem52 sequence, which contains
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a sequence with similarity to the regulatory sequences in
other paramyxoviruses (Figure 1A).
Another reported angiotensin II-induced gene,
Angrem104 (accession no. AF367870), appears to be a
paramyxovirus phosphoprotein (P) gene. The reported
Angrem104 sequence is 1690-nt long (10,11). The ATG
that begins the P ORF is at position 90. Based on the
reported sequence, an ORF is present from nt 90 to 1133,
and the theoretical translation of this ORF yields a protein
with homology to paramyxovirus P proteins but which is
shorter than reported P proteins. However, the insertion of
a single T residue between nucleotides at positions 1130
and 1131 results in a single reading frame that ends at posi-
tion 1579 of the reported Angrem104 sequence and
encodes a protein of 496 aa. Alignment of the modified
protein sequence to the Nipah virus Pprotein shows 20.1%
amino acid identity over the length of the putative OPmV
protein. 
Paramyxovirus Pgenes frequently encode multiple pro-
teins (13). For example, C proteins are encoded by alter-
nate ORFs near the 5′ end of P genes in a number of
paramyxoviruses. In addition, through the process of
“RNA editing,” the site-specific insertion of nontemplate
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Figure 1. Angrem52 and Angrem104 appear to be paramyxovirus genes. A) Gene positions of a generic paramyxovirus and predicted
genome position of Angrem104 (top), the phosphoprotein (P) gene, Angrem52 (bottom), the matrix protein (M) and fusion protein (F)
genes. A potential editing site (nucleotides 783–795), which might allow production from the OPmV P gene of V and W/D proteins, is
shown in genomic (negative) sense aligned with the proposed editing sites of Nipah virus (NC_002728) (1) and Hendra viruses
(NC_001906). The full-length P open reading frame (ORF) was obtained by inserting an additional nucleotide in the reported Angrem104
sequence (see text). Angrem52 is predicted to be a “read-through” product of the M and F genes of a novel paramyxovirus. The full-
length F ORF was obtained by making 5 changes to the reported Angrem52 sequence (see text). Putative gene-end, intergenic (IG), and
gene-start transcription regulatory signals lying between OPmV M and F genes are shown aligned to the corresponding signals from
Nipah and Hendra virus (shown in genomic sense [12]). B) The putative OPmV F protein contains a fusion peptide. The sequences sur-
rounding the F protein cleavage sites, including most fusion peptides, of several paramyxoviruses, including putative OPmV, were aligned
by using the AlignX program of the Vector NTI6 software package. The arrow indicates the cleavage site. Residues in red are absolute-
ly conserved. Residues in blue are conserved in most sequences. C) Organization of the putative OPmV P gene, allowing translation of
P, V, W, and C ORFs. D) Alignment of cysteine-rich carboxy-termini of the putative OPmV and Nipah virus V proteins. The conserved
carboxy-terminal regions of the V proteins were aligned by using the AlignX program of the Vector NTI6 software package. Conserved
residues are indicated in red, except for conserved cysteines, which are in blue. Underlined residues are conserved among all paramyx-
ovirus V proteins.encoded nucleotides by the viral polymerase, additional
proteins, such as V and W proteins, can be produced (13).
These latter proteins share amino-terminal sequences with
the P proteins but differ after the editing site and thus have
distinct carboxy-terminal ends (13). In the case of V pro-
teins, the unique carboxy-terminus is characterized by a
relatively conserved cysteine-rich domain. Analysis of the
modified Angrem104 sequence identifies a C ORF (from
positions 109 to 598) potentially encoding a 163-aa pro-
tein. In addition, a possible RNA editing signal similar to
that found in the P gene of other paramyxoviruses is pres-
ent (Figure 1A). One or 2 additional G residues added to
the newly synthesized mRNA transcribed from this tem-
plate sequence (i.e., the singly edited mRNA sequence
would then be AAAAAAGGG) would give rise to mRNAs
encoding a V or W protein (Figure 1C). The V ORF would
begin at nt 90 of our modified Angrem104 sequence and
end at position 964 of the modified Angrem104 sequence
(this numbering does not count the additional G residue
found in the edited mRNA). The carboxy-terminus of the
predicted V protein is cysteine-rich, as expected for a
paramyxovirus V protein (Figure 1D). The W ORF would
also begin at nt 90 but would end at nt 1027 of the original
Angrem104 sequence (again not including the 2 extra G
nucleotides introduced by editing [Figure 1C]).
Based on the similarity of the predicted Angrem52
and Angrem104 sequences to paramyxovirus protein
sequences, a reasonable conclusion is that Angrem52 and
Angrem104 are actually paramyxovirus genes.
Phylogenetic comparison of the putative OPmV P, M, and
F proteins suggests that the putative OPmV belongs to a
previously uncharacterized genus in the paramyxovirus
family. Comparison of the M proteins may provide the
most compelling argument for the uniqueness of the puta-
tive OPmV, given that an intact ORF was present in the
Angrem52 nucleotide sequence and did not require addi-
tional manipulation before analysis. The putative OPmV
M is found to be slightly more similar to the Henipah
virus genus than to other paramyxoviruses but distinct
from even Nipah and Hendra virus (Figure 2A). Likewise,
the putative OPmV F protein shows the highest degree of
sequence identity with the F protein of tupaia paramyx-
ovirus (Figure 2B). Finally, analysis of the putative
OPmV P gene places the putative OPmV protein on a sep-
arate branch with slightly greater similarity to the P pro-
teins of Hendra and Nipah virus (Figure 2C). Final
evidence for classifying the putative OPmV in a distinct
phylogenetic group is the fact that the nucleotide
sequences of its genes do not show substantial similarity
to other paramyxoviruses (data not shown). Typically,
notable nucleotide identity is seen between members of a
paramyxovirus genus but is not seen when nucleotide
sequences are compared across genera. For example, mor-
billivirus M genes share nucleotide identity with one
another but not with the M genes of Henipah viruses (data
not shown).
Conclusions
The Angrem52 and Angrem104 genes were identified
by a reverse transcriptase–polymerase chain reaction (RT-
PCR)–based method from primary human mesangial cells
(10,11). Basal expression of each gene was detected, but
each gene was identified as an angiotensin II–induced gene
(10,11). The apparent presence of viral genes in a primary
human cell culture system is intriguing. The presence of
these genes could reflect the presence of a virus in any of
several states. These include the presence of an actively
replicating, fully competent virus; the presence in the cells
of a persistent virus infection; or the presence of a replicat-
ing but defective virus (14). Although unlikely, these genes
could also reflect the integration into the cellular genome
of a viral genome as cDNA (15,16). 
We have performed several experiments in an effort to
determine whether these paramyxoviruslike sequences are
universally present within the human genome or whether
they represent a very common infection found in human
mesangial cells. Searches of publicly available human and
mouse sequence databases have not identified proteins or
predicted proteins with homology to the putative OPmV
sequences (data not shown). We obtained a human 12-tis-
sue, multiple tissue, Northern blot from Clontech and
probed this with recombinant probes corresponding to the
putative OPmVM and Pgenes. No specific signal could be
obtained under conditions in which a β-actin probe effi-
ciently recognized its mRNA (data not shown). We also
screened 4 lots of Clonetics primary human mesangial
cells (Cambrex, East Rutherford, NJ) for the presence of
the putative OPmV mRNAs and products when the cells
were untreated and after treatment with a range of concen-
trations of human angiotensin II (Sigma Chemical Co., St.
Louis, MO). RT-PCR analysis using a number of primer
sets for each of the putative OPmV genes yielded consis-
tently negative results, and antibodies raised against
recombinant forms of the putative OPmV M and Pproteins
failed to detect the putative OPmV proteins (data not
shown). Based on these data, it appears that the putative
OPmV genes are not human genes and are not universally
expressed in human mesangial cells.
The source of OPmV, the genes of which were identi-
fied as Angrem52 and Angrem104, remains unclear.
Infection of the cells after their establishment in culture
cannot be excluded, nor can contamination of the PCR
reactions used to identify Angrem52 and Angrem104 be
ruled out. However, the cells may also have been infected
in vivo before the generation of the primary cell culture. In
this respect, the putative OPmV might be similar to simian
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Figure 2. Phylogenetic comparison of OPmV proteins to
other paramyxovirus proteins. A) Phylogenetic tree
showing the relationship of the putative OPmV M pro-
tein to the M proteins of representative members of the
various genera in the family Paramyxoviridae. B)
Phylogenetic tree showing the relationship of the puta-
tive OPmV F protein to the F proteins of other represen-
tative paramyxoviruses. C) Phylogenetic tree showing
the relationship of the putative OPmV P protein to the P
proteins of other representative paramyxoviruses.
Sequence alignments were made with the ClustalW
method of the AlignX program of the Vector NTI6 soft-
ware package. The trees were generated from these
alignments by using neighbor-joining methods through
the computer program MEGA version 2.1 (available
from http://www.megasoftware.net/). The position of the
putative OPmV sequences are indicated by arrows; dis-
tance bars, which represent 0.2 amino acid changes
per position, are shown below the trees. The
sequences from which the trees were constructed are
as follows: Mossman, Mossman virus (NC_005339);
Tupaia, Tupaia paramyxovirus (NC_002199); NiV,
Nipah virus (NC_002728); HeV, Hendra virus
(NC_001906); SeV, Sendai virus (AB065188); hPIV-1,
human parainfluenza virus 1 (NC_003461); hPIV-3,
human parainfluenza virus type 3 (NC_001796); bPIV-
3, bovine parainfluenza virus type 3 (AF178655); hRSV,
human respiratory syncytial virus (GI:133665); BRSV,
bovine respiratory syncytial virus (NC_001989); PMV,
pneumonia virus of mice (AY573814)AMnV, avian
metapneumovirus (AY028582); HMnV, human metap-
neumovirus (NC_004148); SV5, simian paramyxovirus
SV5 (D13868); hPIV-2, human parainfluenza virus type
2 (NC_003443); MuV, mumps virus (AY309060); NDV,
Newcastle disease virus (NC_002617); MeV, measles
virus (AF266288); RPV, rinderpest virus (AB021977,
M21514, M34018); DMV, dolphin morbillivirus
(NC_005283); CDV, canine distemper virus
(NC_005283).DISPATCHES
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virus 5 (SV5), which can cause persistent infection in
monkey kidneys and be detected in monkeys for long peri-
ods after initial infection (14). Given the possibility that
the putative OPmV infects human cells, the potential asso-
ciation of the putative OPmV with human disease is worth
exploring.
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This article was submitted July 5, 2004 to EID . An article
by Schomacker et al., which makes observations similar to ours,
was submitted August 7, 2004 and was published in Virology
(2004;330:178–85). 
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